Delivery Order SPE2DB20D1110-SPE2DB24FJ77E
Award Date 11/29/23
Potential Completion Date 11/30/23
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,556.64 firm fixed-price delivery order is for the supply of Micardis HCT 80-25 mg tablets, a cardiovascular medication, with an ultimate completion date of January 18, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,074.58 firm-fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a completion date of January 31, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.24 delivery order contract is for the supply of Micardis HCT 80-25 mg tablets, with a period of performance through March 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,880.50 delivery order contract is for Micardis HCT 80-25 mg tablet units and has a completion date of March 22, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.38 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a prescription medication. The contract has a completion date of September 18, 2023 and was awarded on September 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.56 firm-fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of November 13, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.52 firm fixed-price delivery order is for the supply of Micardis HCT 80-25 mg tablets, a cardiovascular medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,373.44, is a firm fixed-price delivery order for the supply of Micardis HCT 80-25 mg tablets. The contract has a completion date of November 26, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,445.13 firm fixed-price delivery order is for the supply of Micardis HCT 80-25 mg tablet units, a prescription medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of August 20, 2024 and was awarded on August 19, 2024. This order is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,063.60 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The award is not designated as a set-aside contract. The contract has an ultimate completion date of September 18, 2024 and is associated with a larger Indefinite Delivery Contract (IDC)...